Ramita Tandon is Chief Clinical Trials officer at Walgreens, where she is responsible for leading and driving growth for the company’s new clinical trials business. Working across health care and life sciences to enable next-generation clinical trials so that breakthrough treatments reach patients faster, her team focuses on improving access, awareness, and trust by matching diverse patient populations to sponsor-led trials and reducing operational complexities and patient burdens.

Tandon brings more than 25 years of leadership and operational experience across a portfolio of industry-leading businesses and services in real-world evidence and patient-centered health outcomes. Prior to joining Walgreens, she served as the Chief Operating Officer at Trio Health; earlier, she was the Executive Vice President, Commercialization and Outcomes at ICON.

Tandon was named to Drug Store News’s Top Women in Health, Wellness & Beauty 2022 for Business Excellence, Fierce Healthcare’s 2022 Women of Influence, and the 2018 PharmaVOICE 100. Under her leadership, the Walgreens clinical trials business was nominated at the 2022 Prix Galien USA in the category for “Incubators, Accelerators and Equity,” commended in the 2022 Clinical Trials Arena Excellence Awards, and was shortlisted in the PRWeek Healthcare Awards 2023 “Best Healthcare Product Launch” category.

Tandon is an internationally recognized speaker whose focus is on how to bridge the gap between commercial and clinical development. She serves on the Board of Directors for the Center for Healthcare Innovation, and is a graduate of the University of Michigan and the Boston University School of Public Health.

Aspen Health Health, Healthcare, Pharmaceutical, Innovation, Public Health, Global Health, Milken Institute,